Scarica l'app Stockscreener
15.47
0.77%
-0.12
Dopo l'orario di chiusura:
15.77
0.30
+1.94%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KROS Giù?
Forum
Previsione
Keros Therapeutics Inc Borsa (KROS) Ultime notizie
Keros Therapeutics reports positive data for DMD drug candidate By Investing.com - Investing.com Canada
Sector Leaders Rotate Capital Into Keros Therapeutics Inc.Weekly Volume Report & Community Driven Trade Alerts - beatles.ru
Published on: 2025-09-08 19:14:17 - beatles.ru
Keros Therapeutics reports positive data for DMD drug candidate - Investing.com
Keros Therapeutics Presents Promising Phase 1 Trial Data - TipRanks
Parkman Healthcare Partners LLC Lowers Stock Holdings in Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics Presents Additional Clinical Data from - GlobeNewswire
Sustained Bone Density Gains: Keros' KER-065 Shows Promise in Phase 1 DMD Treatment Trial Results - Stock Titan
Keros Therapeutics, Inc. $KROS Shares Sold by Alkeon Capital Management LLC - MarketBeat
Invesco Ltd. Grows Stock Position in Keros Therapeutics, Inc. $KROS - MarketBeat
Can Keros Therapeutics Inc. reach all time highs this yearMarket Risk Summary & Safe Entry Point Identification - beatles.ru
Keros Therapeutics, Inc. $KROS is ADAR1 Capital Management LLC's 8th Largest Position - MarketBeat
Russell Investments Group Ltd. Sells 25,067 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
PDT Partners LLC Buys New Position in Keros Therapeutics, Inc. $KROS - MarketBeat
What institutional flow reveals about Keros Therapeutics Inc.Portfolio Value Report & Daily Stock Momentum Reports - Newser
What MACD and RSI say about Keros Therapeutics Inc.Weekly Risk Summary & AI Optimized Trading Strategy Guides - Newser
Real time alert setup for Keros Therapeutics Inc. performance2025 Valuation Update & AI Powered Market Trend Analysis - Newser
Keros Therapeutics Inc. stock outlook for YEARWeekly Risk Summary & AI Powered Market Trend Analysis - Newser
464,895 Shares in Keros Therapeutics, Inc. $KROS Purchased by DRW Securities LLC - MarketBeat
Will Keros Therapeutics Inc. benefit from green energy policiesJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - خودرو بانک
Is Keros Therapeutics Inc. backed by strong institutional buyingDollar Strength & Real-Time Sentiment Analysis - خودرو بانک
Can Keros Therapeutics Inc. lead its sector in growthEarnings Recap Report & Daily Profit Focused Stock Screening - خودرو بانک
What candlestick patterns are forming on Keros Therapeutics Inc.July 2025 Selloffs & Verified Momentum Stock Ideas - Newser
Short interest data insights for Keros Therapeutics Inc.Market Sentiment Report & AI Forecast Swing Trade Picks - Newser
Keros Therapeutics Inc. stock trend forecastCPI Data & Fast Gaining Stock Strategy Reports - Newser
How to build a dashboard for Keros Therapeutics Inc. stock2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Can Keros Therapeutics Inc. hit a new high this monthJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
Is this a good reentry point in Keros Therapeutics Inc.Weekly Stock Report & Daily Oversold Bounce Ideas - Newser
Exit strategy if you’re trapped in Keros Therapeutics Inc.Jobs Report & Weekly Consistent Profit Watchlists - Newser
Is Keros Therapeutics Inc. forming a breakout patternWeekly Trade Analysis & Weekly High Return Forecasts - خودرو بانک
103,826 Shares in Keros Therapeutics, Inc. $KROS Acquired by Jump Financial LLC - MarketBeat
Charles Schwab Investment Management Inc. Sells 37,759 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
Real time social sentiment graph for Keros Therapeutics Inc.2025 Price Targets & Real-Time Price Movement Reports - Newser
Walleye Capital LLC Sells 47,163 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics Inc. stock chart pattern explained2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - Newser
Intraday pattern recognizer results for Keros Therapeutics Inc.2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
Pattern recognition hints at Keros Therapeutics Inc. upside2025 Geopolitical Influence & AI Driven Price Predictions - Newser
Published on: 2025-09-03 23:43:48 - Newser
Analyzing Keros Therapeutics Inc. with risk reward ratio chartsWeekly Trade Recap & Verified Momentum Watchlists - Newser
Is it time to cut losses on Keros Therapeutics Inc.Trade Risk Summary & Long-Term Safe Investment Plans - Newser
Statistical indicators supporting Keros Therapeutics Inc.’s strengthPortfolio Risk Summary & Comprehensive Market Scan Reports - Newser
Applying chart zones and confluence areas to Keros Therapeutics Inc.IPO Watch & Safe Capital Growth Trade Ideas - Newser
Does Keros Therapeutics Inc. qualify in momentum factor screening2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - Newser
Technical signs of recovery in Keros Therapeutics Inc.Portfolio Update Summary & Safe Capital Growth Tips - Newser
How to escape a deep drawdown in Keros Therapeutics Inc.Analyst Upgrade & Weekly Watchlist of Top Performers - Newser
Published on: 2025-09-03 02:58:10 - Newser
Tick level data insight on Keros Therapeutics Inc. volatilityJuly 2025 Outlook & Daily Momentum Trading Reports - Newser
Vanguard Group Inc. Has $26.15 Million Stock Holdings in Keros Therapeutics, Inc. $KROS - MarketBeat
Leading vs lagging indicators on Keros Therapeutics Inc. performanceJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
0.75%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):